Hospitals and healthcare systems are being charged with the health and wellness of the community of patients they serve. Over the past decade, hospitals have actively acquired physician practices and have moved towards a population health management model with the goal of reducing costs while improving patient care and outcomes. As a consequence of hospitals building their provider networks through acquisition, they have also assumed risk in the management of CPDs for their patient population. CPDs include opioids, benzodiazepines, amphetamines, stimulants, muscle relaxers, and sleep aids. CPDs can be effectively monitored for misuse, abuse, and diversion with a comprehensive medication monitoring protocol utilizing high sensitivity definitive toxicology testing.
LabSource works closely with hospital clients delivering an effective medication monitoring protocol through Risk Stratification models, pharmacogenetics and the latest in toxicology testing methodology to help hospitals and providers quickly recognize potential misuse, abuse, and diversion of CPDs, as well as testing for illicit drug use. Utilizing a dedicated clinical toxicology laboratory as a part of your medication monitoring protocol will deliver to your providers consistent and comprehensive toxicology reporting. The LabSource Science Leadership team has extensive experience working in the hospital environment and can provide research support, payer support, hospital client bill, in-sourcing toxicology laboratory development, and EMR & LIS interfaces.
Ask about our Hospital Client Bill Program
Successful Hospital Management of CPDs includes:
How can Hospitals Use Pharmacogenetics to Improve Patients' Outcomes?
30 Day Account Integration – LabSource Quickly Communicates Issues That Can Affect Testing and Turn-Around Time.
Solid Phase Extraction & Concentrate Eliminates Interferences and Extracts Drugs to Increase Sensitivity. Evaporates Liquid Leaving High Concentrations of Drugs for Maximum Sensitivity.
Patient Results are Compared to the Patient’s Previous Results.
Automatic Re-test and Verification of Unexpected Results; We Re-test 10% of Specimens.
Ask About Our Clinical Toxicology Testing Services